1
|
Waterhouse M, Themeli M, Bertz H, Zoumbos
N, Finke J and Spyridonidis A: Horizontal DNA transfer from donor
to host cells as an alternative mechanism of epithelial chimerism
after allogeneic hematopoietic cell transplantation. Biol Blood
Marrow Transplant. 17:319–329. 2011. View Article : Google Scholar : PubMed/NCBI
|
2
|
Network NCCN: NCCN Clinical Practice
Guidelines in Oncology - Genetic/Familial high-risk assessment:
Breast and ovarian. Version. 2016.
|
3
|
Hong YC, Liu HM, Chen PS, Chen YJ, Lyou
JY, Hu HY, Yi MF, Lin JS and Tzeng CH: Hair follicle: A reliable
source of recipient origin after allogeneic hematopoietic stem cell
transplantation. Bone Marrow Transplant. 40:871–874. 2007.
View Article : Google Scholar : PubMed/NCBI
|
4
|
Tran SD, Pillemer SR, Dutra A, Barrett AJ,
Brownstein MJ, Key S, Pak E, Leakan RA, Kingman A, Yamada KM, et
al: Differentiation of human bone marrow-derived cells into buccal
epithelial cells in vivo: A molecular analytical study. Lancet.
361:1084–1088. 2003. View Article : Google Scholar : PubMed/NCBI
|
5
|
Mancini-DiNardo D, Landon M, Abbott B,
Elias M, Rinsky J and Roa B: Complexities in genetic testing for
allogenic bone marrow transplant recipients and patients with
hematologic malignancies. Journal. 2016.http://www.ashg.org/2014meeting/abstracts/fulltext/f140122408.htm
|
6
|
Novaković S, Milatović M, Cerkovnik P,
Stegel V, Krajc M, Hočevar M, Zgajnar J and Vakselj A: Novel
BRCA1BRCA2 pathogenic mutations in Slovene hereditary breast and
ovarian cancer families. Int J Oncol. 41:1619–1627. 2012.PubMed/NCBI
|
7
|
Stegel V, Krajc M, Zgajnar J, Teugels E,
De Grève J, Hočevar M and Novaković S: The occurrence of germline
BRCA1BRCA2 sequence alterations in Slovenian population. BMC Med
Genet. 12:92011. View Article : Google Scholar : PubMed/NCBI
|
8
|
Jiang Y, Jahagirdar BN, Reinhardt RL,
Schwartz RE, Keene CD, Ortiz-Gonzalez XR, Reyes M, Lenvik T, Lund
T, Blackstad M, et al: Pluripotency of mesenchymal stem cells
derived from adult marrow. Nature. 418:41–49. 2002. View Article : Google Scholar : PubMed/NCBI
|
9
|
Körbling M, Katz RL, Khanna A, Ruifrok AC,
Rondon G, Albitar M, Champlin RE and Estrov Z: Hepatocytes and
epithelial cells of donor origin in recipients of peripheral-blood
stem cells. N Engl J Med. 346:738–746. 2002. View Article : Google Scholar : PubMed/NCBI
|
10
|
Krause DS, Theise ND, Collector MI,
Henegariu O, Hwang S, Gardner R, Neutzel S and Sharkis SJ:
Multi-organ, multi-lineage engraftment by a single bone
marrow-derived stem cell. Cell. 105:369–377. 2001. View Article : Google Scholar : PubMed/NCBI
|
11
|
Mezey E, Chandross KJ, Harta G, Maki RA
and McKercher SR: Turning blood into brain: Cells bearing neuronal
antigens generated in vivo from bone marrow. Science.
290:1779–1782. 2000. View Article : Google Scholar : PubMed/NCBI
|
12
|
Orlic D, Kajstura J, Chimenti S, Jakoniuk
I, Anderson SM, Li B, Pickel J, McKay R, Nadal-Ginard B, Bodine DM,
et al: Bone marrow cells regenerate infarcted myocardium. Nature.
410:701–705. 2001. View
Article : Google Scholar : PubMed/NCBI
|
13
|
Kim HS, Lee SW, Choi YJ, Shin SW, Kim YH,
Cho MS, Lee SN and Park KH: Novel germline mutation of BRCA1 gene
in a 56-year-old woman with breast cancer, ovarian cancer, and
diffuse large B-cell lymphoma. Cancer Res Treat. 47:534–538. 2015.
View Article : Google Scholar : PubMed/NCBI
|
14
|
Friedenson B: The BRCA1/2 pathway prevents
hematologic cancers in addition to breast and ovarian cancers. BMC
Cancer. 7:1522007. View Article : Google Scholar : PubMed/NCBI
|
15
|
Risch HA, McLaughlin JR, Cole DE, Rosen B,
Bradley L, Kwan E, Jack E, Vesprini DJ, Kuperstein G, Abrahamson
JL, et al: Prevalence and penetrance of germline BRCA1BRCA2
mutations in a population series of 649 women with ovarian cancer.
Am J Hum Genet. 68:700–710. 2001. View
Article : Google Scholar : PubMed/NCBI
|
16
|
Shih HA, Nathanson KL, Seal S, Collins N,
Stratton MR, Rebbeck TR and Weber BL: BRCA1 and BRCA2 mutations in
breast cancer families with multiple primary cancers. Clin Cancer
Res. 6:4259–4264. 2000.PubMed/NCBI
|